Follow
Frank Vari
Frank Vari
Unknown affiliation
Verified email at imb.uq.edu.au
Title
Cited by
Cited by
Year
Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
F Vari, D Arpon, C Keane, MS Hertzberg, D Talaulikar, S Jain, Q Cui, ...
Blood, The Journal of the American Society of Hematology 131 (16), 1809-1819, 2018
2952018
Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma
K Jones, F Vari, C Keane, P Crooks, JP Nourse, LA Seymour, D Gottlieb, ...
Clinical cancer research 19 (3), 731-742, 2013
1152013
Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration
JWD Tobin, C Keane, J Gunawardana, P Mollee, S Birch, T Hoang, J Lee, ...
Journal of Clinical Oncology 37 (34), 3300, 2019
1122019
A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A* 0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer
RL Prue, F Vari, KJ Radford, H Tong, MY Hardy, R D’Rozario, ...
Journal of immunotherapy 38 (2), 71-76, 2015
962015
CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8+ T cells
M Braun, AR Aguilera, A Sundarrajan, D Corvino, K Stannard, S Krumeich, ...
Immunity 53 (4), 805-823. e15, 2020
942020
CD4+ Tumor infiltrating lymphocytes are prognostic and independent of R‐IPI in patients with DLBCL receiving R‐CHOP chemo‐immunotherapy
C Keane, D Gill, F Vari, D Cross, L Griffiths, M Gandhi
American journal of hematology 88 (4), 273-276, 2013
932013
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study
C Keane, F Vari, M Hertzberg, KA Lê Cao, MR Green, E Han, JF Seymour, ...
The Lancet Haematology 2 (10), e445-e455, 2015
862015
The T-cell receptor repertoire influences the tumor microenvironment and is associated with survival in aggressive B-cell lymphoma
C Keane, C Gould, K Jones, D Hamm, D Talaulikar, J Ellis, F Vari, S Birch, ...
Clinical Cancer Research 23 (7), 1820-1828, 2017
762017
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
MK Gandhi, T Hoang, SC Law, S Brosda, K O’Rourke, JWD Tobin, F Vari, ...
Blood, The Journal of the American Society of Hematology 137 (11), 1468-1477, 2021
702021
The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma
K Jones, L Wockner, RM Brennan, C Keane, PK Chattopadhyay, ...
Clinical & Experimental Immunology 183 (2), 206-220, 2016
542016
EBV microRNA-BHRF1-2-5p targets the 3′ UTR of immune checkpoint ligands PD-L1 and PD-L2
AS Cristino, J Nourse, RA West, MB Sabdia, SC Law, J Gunawardana, ...
Blood, The Journal of the American Society of Hematology 134 (25), 2261-2270, 2019
532019
Restoration of tolerance to rat hepatic allografts by spleen‐derived passenger leukocytes
Y Shimizu, S Goto, R Lord, F Vari, C Edwards‐Smith, S Chiba, D Schlect, ...
Transplant international 9 (6), 593-595, 1996
531996
Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples
JP Nourse, P Crooks, C Keane, D Nguyen-Van, S Mujaj, N Ross, K Jones, ...
Journal of virological methods 184 (1-2), 46-54, 2012
342012
Targeting an adenosine-mediated “don’t eat me signal” augments anti-lymphoma immunity by anti-CD20 monoclonal antibody
K Nakamura, M Casey, H Oey, F Vari, J Stagg, MK Gandhi, MJ Smyth
Leukemia 34 (10), 2708-2721, 2020
332020
Human peripheral blood DNAM-1neg NK cells are a terminally differentiated subset with limited effector functions
KA Stannard, S Lemoine, NJ Waterhouse, F Vari, L Chatenoud, ...
Blood advances 3 (11), 1681-1694, 2019
332019
Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8+ T-cell epitopes
D Nguyen-Van, C Keane, E Han, K Jones, JP Nourse, F Vari, N Ross, ...
American journal of blood research 1 (2), 146, 2011
332011
Allograft acceptance and rejection, mediated by a liver suppressor factor, LSF-1, purified from serum of liver transplanted rats
C Edwards-Smith, S Goto, R Lord, Y Shimizu, F Vari, N Kamada
Transplant Immunology 4 (4), 287-292, 1996
331996
NOVEL IMMUNOSUPPRESSIVE PROTEINS PURIFIED FROM THE SERUM OF LIVER-RETRANSPLANTED RATS1
S Goto, R Lord, E Kobayashi, F Vari, C Edwards-Smith, N Kamada
Transplantation 61 (8), 1147-1151, 1996
291996
Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients
R Wilkinson, K Woods, R D’Rozario, R Prue, F Vari, MY Hardy, Y Dong, ...
Cancer Immunology, Immunotherapy 61, 169-179, 2012
262012
The characterization of reconstituted passenger leukocytes on the induction of tolerance in rat liver transplantation
S Chiba, S Goto, Y Shimizu, F Vari, R Lord, C Edwards‐Smith, ...
Transplant international 10 (5), 350-356, 1997
261997
The system can't perform the operation now. Try again later.
Articles 1–20